Topical 5-Fluorouracil Elicits Regressions of BRAF Inhibitor–Induced Cutaneous Squamous Cell Carcinoma
REGISTER
The information on this site is not intended or implied to be a substitute for professional medical advice, diagnosis or treatment. Content within the patient forum is user-generated and has not been reviewed by medical professionals. Other sections of the Melanoma Research Foundation website include information that has been reviewed by medical professionals as appropriate. All medical decisions should be made in consultation with your doctor or other qualified medical professional.

Topical 5-Fluorouracil Elicits Regressions of BRAF Inhibitor–Induced Cutaneous Squamous Cell Carcinoma

› Forums › Cutaneous Melanoma Community › Topical 5-Fluorouracil Elicits Regressions of BRAF Inhibitor–Induced Cutaneous Squamous Cell Carcinoma

This topic has been reported for inappropriate content

  • Post
    • December 19, 2012 at 11:59 pm
    lou2
    Participant

    Letter to the Editor

    Journal of Investigative Dermatology (2013) 133, 274–276; doi:10.1038/jid.2012.268; published online 16 August 2012

    Letter to the Editor

    Journal of Investigative Dermatology (2013) 133, 274–276; doi:10.1038/jid.2012.268; published online 16 August 2012

    Topical 5-Fluorouracil Elicits Regressions of BRAF Inhibitor–Induced Cutaneous Squamous Cell Carcinoma

    Amaya Viros1,2, Robert Hayward1, Matthew Martin1, Sharona Yashar3, Clarissa C Yu4, Berta Sanchez-Laorden1, Alfonso Zambon5, Dan Niculescu-Duvaz5, Caroline Springer5, Roger S Lo4 and Richard Marais1,6

    1. 1Signal Transduction Team, The Institute of Cancer Research, London, UK
    2. 2Seccio Dermatologia, Departament de Medicina, Hospital Universitari Vall d'Hebron, Barcelona, Spain
    3. 3Department of Pathology and Laboratory Medicine, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, California, USA
    4. 4Division of Dermatology, Department of Medicine, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, California, USA
    5. 5Gene and Oncogene Targeting Team, CR-UK Cancer Therapeutics Unit, The Institute of Cancer Research, Sutton, Surrey, UK
    6. 6Molecular Oncology Laboratory, The Paterson Institute for Cancer Research, Manchester, UK

    Correspondence: Richard Marais, E-mail: rmarais@picr.man.ac.uk

    Abbreviations:

    CuSCCs, cutaneous squamous cell carcinomas; DMBA, 7,12-dimethylbenz-(a)anthracene; KA, keratoacanthomas; MAPK, mitogen-activated protein kinase; TPA, 12-O-tetradecanoyl-phorbol-13-acetate; 5-FU, 5-fluorouracil

     

    [Sorry, no abstract, but the title says it all.]

Viewing 2 reply threads
  • Replies
      • December 20, 2012 at 2:33 am
      POW
      Participant

      You can read the article here:  http://www.nature.com/jid/journal/v133/n1/full/jid2012268a.html

      Basically, they did studies in mice and in 2 humans and suggest that 5-FU cream can prevent the occurrance of cutaneous squamous cell carcinomas while you're on Zelboraf or Dabrafenib. Mostly conceptual, pre-clinical for now.

      • December 20, 2012 at 2:33 am
      POW
      Participant

      You can read the article here:  http://www.nature.com/jid/journal/v133/n1/full/jid2012268a.html

      Basically, they did studies in mice and in 2 humans and suggest that 5-FU cream can prevent the occurrance of cutaneous squamous cell carcinomas while you're on Zelboraf or Dabrafenib. Mostly conceptual, pre-clinical for now.

        • December 20, 2012 at 2:53 am
        lou2
        Participant

        Thank you for your reply.  It was good to learn what stage this research is in.  But maybe this will cause doctors to try it on their own even before any bigger studies are organized.  I paid attention to the study because it seemed to me that a treatment which reduced one type of skin cancer but allowed others to grow had some significant downsides.

        • December 20, 2012 at 2:53 am
        lou2
        Participant

        Thank you for your reply.  It was good to learn what stage this research is in.  But maybe this will cause doctors to try it on their own even before any bigger studies are organized.  I paid attention to the study because it seemed to me that a treatment which reduced one type of skin cancer but allowed others to grow had some significant downsides.

        • December 20, 2012 at 2:53 am
        lou2
        Participant

        Thank you for your reply.  It was good to learn what stage this research is in.  But maybe this will cause doctors to try it on their own even before any bigger studies are organized.  I paid attention to the study because it seemed to me that a treatment which reduced one type of skin cancer but allowed others to grow had some significant downsides.

      • December 20, 2012 at 2:33 am
      POW
      Participant

      You can read the article here:  http://www.nature.com/jid/journal/v133/n1/full/jid2012268a.html

      Basically, they did studies in mice and in 2 humans and suggest that 5-FU cream can prevent the occurrance of cutaneous squamous cell carcinomas while you're on Zelboraf or Dabrafenib. Mostly conceptual, pre-clinical for now.

Viewing 2 reply threads
  • You must be logged in to reply to this topic.
About the MRF Patient Forum

The MRF Patient Forum is the oldest and largest online community of people affected by melanoma. It is designed to provide peer support and information to caregivers, patients, family and friends. There is no better place to discuss different parts of your journey with this cancer and find the friends and support resources to make that journey more bearable.

The information on the forum is open and accessible to everyone. To add a new topic or to post a reply, you must be a registered user. Please note that you will be able to post both topics and replies anonymously even though you are logged in. All posts must abide by MRF posting policies.

Popular Topics